-
Most Recent
Search Results
240 results for icgn
Why You Should Keep Your Distance from Ocugen Stock
Off and on the price chart OCGN stock, today’s reality is bleak for shareholders, but being a bear poses its own challenges.
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
While the contrarian bullish argument for OCGN stock has picked up considerable chatter, this is an extremely risky trade.
Entry Into Infectious Disease Field Creates Opportunity for Ocugen
Now that Ocugen is collaborating to develop a Covid-19 vaccine, OCGN stock holders should brace for a possible regulatory authorization.
The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat
No one wants to be the bearer of bad news, but we must acknowledge that the vertical move in OCGN stock is turning out to…
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
Ocugen Has a Longer Road To Paying off Than People Think
Ocugen seems to have delivered good news in recent days, yet OCGN stock is right back where it started. Does that create a buying opportunity?
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it’s best to avoid OCGN stock.
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely
Biotech Speculators Should Try a Small Position in Ocugen Stock
Probably because it’s not a buzzworthy coronavirus stock, you might not hear much about OCGN stock but it still has strong upside potential.
Icon Energy Fund Offers Commodity Focus to IRA Investors
With top oil stocks like Exxon and Chevron, the Icon Energy Fund is a good way to buy the energy sector and the rise in…
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn’t be applying for a crucial authorization.
The Slide in Ocugen Could Be a Slide to a Homerun
Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin.
Ocugen Stock Looks Overinflated
Celebrating Ocugen’s value-added collaboration to develop a potentially lifesaving vaccine is fine, but OCGN stock might be too pricey now.
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
Ocugen has been falling after announcing a new share offering. But that’s not the only reason hedge funds are moving away from OCGN stock.
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon.
Investor Fears About Covaxin Have Ocugen Shares on Sale
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock, or an over-priced investigational gene therapy stock — or both.
Ocugen Stock Isn’t Pricing In the Hard Road Ahead
OCGN stock has soared thanks to a Covid-19 vaccine partnership. But Ocugen needs time, capital, and competitive success that may not arrive.
OCGN Stock: What Ocugen Investors Are Saying as Shares Surge Today
Ocugen (OCGN) stock is on the move today as traders on social media push the company higher in a new rally for the shares.
OCGN Stock Alert: Why Ocugen Shares Are Drawing Eyes Ahead of Nov. 3
A key WHO ruling that could materialize as soon as tomorrow has investors considering where OCGN stock could be headed this week.
OCGN Stock Alert: Why Is Ocugen Heating Up Today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company’s coronavirus drug candidate.
OCGN Stock: 2 Big Reasons Ocugen Is Gaining Today
Today, a couple of key catalysts are driving OCGN stock higher by double digits, as investors speculate on what may be announced tomorrow.
4 – 10 of 240 results
